KPV: The α-MSH-Derived Tripeptide in Inflammatory Research

KPV is a tripeptide (Lys-Pro-Val) corresponding to the C-terminal fragment of α-melanocyte-stimulating hormone. Unlike Melanotan II, KPV does not engage melanocortin receptors as a full agonist — its research interest lies in a distinct, receptor-independent anti-inflammatory signalling profile documented across gastrointestinal and dermal models.

Published preclinical work has examined KPV in inflammatory-bowel-disease models, atopic-dermatitis analogues and wound-repair assays. The peptide appears to downmodulate NF-κB signalling and pro-inflammatory cytokine output at low concentrations, positioning it as a useful mechanistic tool separate from the melanocortin-receptor axis.

From a research-practice standpoint, KPV is small, water-soluble and stable. Reconstitution in bacteriostatic water yields a workable stock solution; aliquoting and cold storage extend usable life. Reference-grade material should arrive with HPLC purity confirmation and a batch certificate of analysis.

Comparative designs frequently pair KPV with BPC-157 and TB-500 in gastrointestinal-repair models, and with GHK-Cu in dermal models, to map convergent versus divergent effects on the shared repair pathways.

KPV is supplied strictly as a chemical reference standard for in-vitro and animal research. This article is intended as educational reference material only.